EVERSANA’s Rohit Sood, Executive Vice President, COMPLETE Commercialization shares the four key performance indicators we focus on with every EVERSANA COMPLETE Commercialization program – Speed, Agility, Consistency and Risk Management.
Check out our whitepaper, CHALLENGING TRADITION: The argument for integrated commercialization to improve operational agility, to learn more about what occurs when pharmaceutical companies:
- lean into evolution and adopt an innovative mindset,
- leverage a fully integrated commercialization model to drive operational excellence,
- harness the energy and momentum in an efficient and accessible package and
- turn away from fixed and sluggish structures and toward more efficient partnerships for success.
Author
Rohit is helping EVERSANA disrupt the life sciences industry with innovative commercialization solutions. As a strategy and operations professional, he has served as both an advisor and global strategy leader, driving top-line business growth…